Autologous Transplantation for Multiple Myeloma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1996
The present study was designed in an attempt to prospectively evaluate in a randomized fashion whether further cytotoxic dose intensification, as delivered with two sequential autologous stem-cell transplantations, improved the outcome of younger patients with newly diagnosed multiple myeloma in comparison with a single autologous transplantation.
Epistemonikos ID: 99f96dc87569ac0e00b8e20f274de30bb5a8ccde
First added on: May 04, 2024